Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea

Ksenia Nazarenko (Kiev, Ukraine), Ksenia Nazarenko, Liudmyla Iashyna, Yuri Feschenko, Svitlana Moskalenko, Svitlana Opimah, Iryna Chumak, Inna Zvol

Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Session: Noninvasive ventilation and beyond: novelties and real-life applications
Session type: Thematic Poster
Number: 2185
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ksenia Nazarenko (Kiev, Ukraine), Ksenia Nazarenko, Liudmyla Iashyna, Yuri Feschenko, Svitlana Moskalenko, Svitlana Opimah, Iryna Chumak, Inna Zvol. Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea. Eur Respir J 2016; 48: Suppl. 60, 2185

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors influencing efficacy of BiPAP therapy in severe obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013

Ventilatory management in COPD-associated obstructive sleep apnea syndrome
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015

Improving adherence to treatment in patients with obstructive sleep apnoea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013

Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Impact in adherence to CPAP treatment of a specific consultation for patients with severo obstructive sleep apnoea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Cognition, quality of life and adherence to CPAP after 18-months treatment in obstructive sleep apnea patients
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016


CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Safety of cardiac surgery in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 345s
Year: 2002

Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017

Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011


Clinical significance of transcutaneous PCO2 in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015

The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Health related quality of life after CPAP treatment in patients with obstructive sleep apnoea and patients with overlap syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003